|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Campylobacter jejuni IgA ELISA | Amyloid Beta (N3pE) ELISA Assay | Chagas (Trypanosoma cruzi) IgG ELISA Assay | Insulin ELISA Assay | Total Estrogens ELISA |
| Citations | | | | | |
| Catalog Number | IB05020 | 27716 | IB79809 | IB79167 | IB59134 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Enzyme immunoassay (ELISA) for the determination of human IgA antibodies directed against Campylobacter jejuni in serum or plasma (EDTA, citrate, heparin). For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of Human Amyloid ß (N3pE-42) in brain tissue extract. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) for the determination of IgG class antibodies against Trypanosoma cruzi in human serum or plasma (citrate, heparin). For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) for the determination of Insulin in serum and plasma. FDA exempt, can be used for in-vitro diagnostics. | Enzyme immunoassay (ELISA) for the direct quantitative determination of Total Estrogens in human serum. 510(k) exempt - for in vitro diagnostic use only. |
| Detection Target | Campylobacter jejuni IgA | Anti-Trastuzumab (Herceptin®) | Epstein-Barr Virus (EBNA-1) IgM | Echinococcus IgG | Total Estrogens |
| Sample Type | Serum or plasma (EDTA, citrate, heparin). | Serum and plasma. | Serum, Blood Plasma | Serum and plasma (citrate, heparin). | Serum |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | A calculated cut-off value is used to interpret results of unknowns. | 7.75 to 496 pg/mL | Inquire | 6.25 to 100 µIU/mL | 0 / 20 - 2500 pg/mL |
| Sensitivity | >99% | 30 ng/mL | 0.69 U/mL | 97.22% (95% confidence interval: 85.47% - 99.93%) | 12.4 pg/mL |
| Assay Time | 1 hour (37°C) + 30 min. (37°C) + 30 min. (37°C) = 2 hours total incubation time. | Overnight + 1 hr 30 mins (incubation) | 1 hr 45 mins (incubation) | 1 hr 15 mins (incubation) | 30 min. incubation (RT) + 2 hours (RT) + 30 minute (RT) = 3 hours total incubation time. |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |